These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 2054505

  • 1. [Group- and type-specific antibodies to the gag-gene protein p26 of the human immunodeficiency virus immunological type 2 in infected patients].
    Kliushnik SIu, Selimova LM, Veselovskaia TV, Zaĭdes VM.
    Biull Eksp Biol Med; 1991 Mar; 111(3):283-4. PubMed ID: 2054505
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
    Ayisi NK, Aidoo M.
    West Afr J Med; 1994 Mar; 13(3):164-7. PubMed ID: 7841107
    [Abstract] [Full Text] [Related]

  • 3. Use of the presence of anti-protein gag antibodies as an evolution marker of HIV infection.
    Neguţ EA, Usein CR, Sfartz S, Zugun-Eloae F.
    Roum Arch Microbiol Immunol; 1999 Mar; 58(2):131-46. PubMed ID: 11845452
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Mar; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 5. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
    Pincus SH, Messer KG, Nara PL, Blattner WA, Colclough G, Reitz M.
    J Clin Invest; 1994 Jun; 93(6):2505-13. PubMed ID: 7515393
    [Abstract] [Full Text] [Related]

  • 6. Multiple antigenic epitopes expressed on gag proteins, p26 and p15, of a human immunodeficiency virus (HIV) type 2 as defined with a library of monoclonal antibodies.
    Komatsu H, Tozawa H, Kawamura M, Kodama T, Hayami M.
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):871-81. PubMed ID: 1697178
    [Abstract] [Full Text] [Related]

  • 7. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY, Jin NY, Wang HW, Guo ZR, Fang HH, An RG, Yin Z.
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M, Sabahi F, Mahboudi F, Kazemnejad A.
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [Abstract] [Full Text] [Related]

  • 9. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 10. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F, Vullo V, Cirelli A, Catania S, Mastroianni CM, Contini C, Delia S.
    Boll Ist Sieroter Milan; 1989 Mar; 68(2):115-21. PubMed ID: 2562362
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Mar; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM, Pinheiro S, Sayeid-Al-Jamee M, Alabi A, Kaye S, Sabally S, Sarge-Njie R, Njai H, Joof K, Jaye A, Whittle H, Rowland-Jones S, Dorrell L.
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Introduction of human immunodeficiency virus 2 infection into South Korea.
    Kim SS, Kim EY, Park KY, Suh SD, Park HK, Shin YO, Bae M, Lee JS.
    Acta Virol; 2000 Feb; 44(1):15-22. PubMed ID: 10989687
    [Abstract] [Full Text] [Related]

  • 17. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM, Lewinsohn DA, Riddell SR, Greenberg PD, Mosier DE.
    J Immunol; 1999 Jul 15; 163(2):861-7. PubMed ID: 10395680
    [Abstract] [Full Text] [Related]

  • 18. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA, Morfeldt-Månsson L, Rosen J, Jondal M, Wahren B.
    Clin Exp Immunol; 1989 May 15; 76(2):216-21. PubMed ID: 2503275
    [Abstract] [Full Text] [Related]

  • 19. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ, Vyakarnam A, Cheingsong-Popov R, Callow D, Jones KL, Senior JM, Adams SE, Kingsman AJ, Matear P, Gotch FM.
    AIDS; 1993 Oct 15; 7(10):1315-23. PubMed ID: 8267904
    [Abstract] [Full Text] [Related]

  • 20. [Anti-HIV-1 p17 antibody as anti-HIV agent].
    Tsuchie H, Tochikura A, Kageyama S, Kurimura T.
    Nihon Rinsho; 1993 Sep 15; 51 Suppl():213-8. PubMed ID: 8271386
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.